Hsueh et al. reported that patients undergoing CRT for esophageal cancer had a significantly higher incidence of grade ≥ 3 serious adverse events and a lower treatment completion rate if they had a high NLR and a low serum albumin level [46]. Here, ALB is linked to esophageal cancer.